Report cover image

Designing Patient-Facing Tech for Emerging Biopharma: Key Considerations

Publisher IDC
Published Feb 14, 2025
Length 9 Pages
SKU # IDC19657021

Description

This IDC Perspective explores the unique requirements of EBPs for patient-facing technology, maps the industry landscape, identifies key players involved, and provides guidance to the technology buyer on criteria to drive partnering decisions with patient-facing technology providers."This is the era of embedded unified patient experiences, and of flexible yet integrated solutions. Emerging biopharma will prioritize partners that are willing to customize and build specialized modules that adapt to the needs of niche or rare disease trials, that can embed novel solutions such as gamification or digital therapeutics designed to meet the needs of specific therapeutic areas, and that embed compliance in their product strategy. 'Patient centricity' was never as center stage as it is today, and EBPs are seeking out partners that are truly embedding the patient's voice in their product strategy and partners that are offering flexible pricing models and rapidly deployable solutions. This will help cash-strapped, yet highly innovative emerging biopharma to consolidate their position in the race to be first to market," said Dr. Nimita Limaye, research VP, Life Sciences R&D Strategy and Technology at IDC.

Table of Contents

9 Pages

Executive Snapshot

Situation Overview

Patient-Facing Technologies

Modular Solutions Versus Unified Platforms Versus Hybrid Solutions

Modular Solutions

Unified Platforms

Hybrid Approaches

The Evolving Landscape of Patient-Facing Technology Providers

Advice for the Technology Buyer

Learn More

Related Research

Synopsis

How Do Licenses Work?
Head shot

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.